查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1696290

全球智慧型手机医疗设备市场 - 2025 年至 2033 年

Global Smartphone Enabled Medical Devices Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球智慧型手机医疗设备市场规模达到 227.6 亿美元，预计到 2033 年将达到 891.5 亿美元，2025-2033 年预测期内的复合年增长率为 14.6%。

支援智慧型手机的医疗设备，例如穿戴式心电图监测仪、血糖仪、脉搏血氧仪和数位听诊器，是与手机整合以监测、诊断和管理医疗状况的即时医疗保健工具。这些设备使用智慧型手机应用程式、无线连接和感测器来收集和传输患者资料，提高了可近性、早期疾病检测和个人化医疗，使其成为现代数位健康解决方案的重要组成部分。

市场动态：

驱动因素与约束因素

远距医疗和远距病人监控的普及率不断提高

由于远距医疗和远距病人监控（尤其是在慢性病领域）的兴起，全球智慧型手机医疗设备市场正在获得发展动力。这些设备提供即时资料跟踪，改善患者的治疗效果。行动医疗解决方案的便利性、无线连接的进步以及人工智慧驱动的诊断正在推动市场成长，同时智慧型手机普及率的提高和患者对非侵入性监测的偏好也在推动需求。

例如，2024年12月，领先的数位医学和生物标记公司ElectronRx在2025年消费性电子展上推出了一款旨在满足医疗器材标准的心肺评估应用程式purpleDx。该应用程式可让慢性呼吸系统疾病患者在家中监测肺功能，为临床医生提供即时资料，以客製化治疗方案并改善患者治疗效果。

资料隐私和安全问题

由于资料隐私和安全问题，全球智慧型手机医疗设备市场面临挑战。这些设备收集和传输敏感的患者健康资料，使其容易受到网路威胁和未经授权的存取。缺乏标准化的资料保护法规使合规性变得复杂，而对第三方存取、骇客风险和医疗资讯潜在滥用的担忧阻碍了其广泛采用。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

第三章：市场亮点与策略要点

  • 主要趋势和未来预测

第 4 章：依产品类型分类

  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 5 章：动态

  • 影响因素
    • 驱动程式
      • 远距医疗和远距病人监控的普及率不断提高
      • 智慧型手机和行动健康应用的普及率不断提高
    • 限制
      • 资料隐私和安全问题
      • 监理挑战与审批复杂性
    • 机会
      • 用于即时健康追踪的先进生物感测器的开发
    • 影响分析

第六章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 7 章：按产品类型

  • 诊断设备
  • 监控设备
  • 治疗设备
  • 健身和健康设备
  • 其他的

第 8 章：按应用

  • 病人监护
  • 慢性病管理
  • 健身追踪
  • 远端诊断

第 9 章：按最终用户

  • 医院和诊所
  • 家庭护理设置
  • 健身中心

第 10 章：区域市场分析与成长机会

第 11 章：简介

  • 北美洲
    • 各区域关键动态
      • 我们
      • 加拿大
  • 欧洲
    • 各区域关键动态
      • 德国
      • 英国
      • 法国
      • 西班牙
      • 义大利
      • 欧洲其他地区
  • 拉丁美洲
    • 各区域关键动态
      • 墨西哥
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地区
  • 亚太
    • 各区域关键动态
      • 中国
      • 印度
      • 日本
      • 韩国
      • 亚太其他地区
  • 中东和非洲
    • 各区域关键动态

第 12 章：竞争格局与市场定位

第 13 章：竞争概况与主要市场参与者

  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 14 章：公司简介

  • Apple Inc
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量

第 15 章：财务概况

  • 公司收入
    • 地区收入份额
      • 收入预测
    • 关键进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • 三星电子
  • DexCom 公司
  • 马西莫公司
  • 索诺瓦控股公司
  • 欧拉健康有限公司
  • 博雅有限公司
  • 美敦力
  • 雅培实验室
  • AliveCor, Inc 清单并非详尽无遗

第 16 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 17 章：附录

简介目录
Product Code: MD9413

The global smartphone enabled medical devices market reached US$ 22.76 billion in 2024 and is expected to reach US$ 89.15 billion by 2033, growing at a CAGR of 14.6% during the forecast period 2025-2033.

Smartphone-enabled medical devices, such as wearable ECG monitors, glucose meters, pulse oximeters, and digital stethoscopes, are real-time healthcare tools that integrate with mobile phones to monitor, diagnose, and manage medical conditions. These devices use smartphone applications, wireless connectivity, and sensors to collect and transmit patient data, improving accessibility, early disease detection, and personalized healthcare, making them a crucial part of modern digital health solutions.

Market Dynamics: Drivers & Restraints

Growing Adoption of Telemedicine and Remote Patient Monitoring

The global smartphone-enabled medical devices market is gaining momentum due to the rise in telemedicine and remote patient monitoring, particularly in chronic diseases. These devices offer real-time data tracking, improving patient outcomes. The convenience of mobile health solutions, advancements in wireless connectivity, and AI-driven diagnostics are driving market growth while increasing smartphone penetration and patient preference for non-invasive monitoring are also driving demand.

For instance, in December 2024, ElectronRx, a leading digital medicine and biomarker company, launched purpleDx, a cardiopulmonary assessment app designed to meet medical device standards at CES 2025. The app allows chronic respiratory disease patients to monitor lung function at home, providing real-time data for clinicians to customize treatment plans and improve patient outcomes.

Data Privacy and Security Concerns

The global smartphone-enabled medical devices market faces challenges due to data privacy and security concerns. These devices collect and transmit sensitive patient health data, making them vulnerable to cyber threats and unauthorized access. The lack of standardized data protection regulations complicates compliance, and concerns about third-party access, hacking risks, and potential misuse of medical information hinder widespread adoption.

Segment Analysis

The global smartphone enabled medical devices market is segmented based on product type, application, end-user and region.

Product Type:

The diagnostic devices from product type segment is expected to dominate the smartphone enabled medical devices market with the highest market share

Diagnostic devices are medical instruments used to detect, monitor, and analyze diseases in patients. They range from imaging systems like MRI and CT scans to portable tools like glucose monitors and ECG devices. Modern diagnostic devices offer enhanced accuracy, portability, and real-time data integration, making them essential in clinical and home healthcare settings.

The diagnostic devices market is driven by the rise in chronic and infectious diseases, fueled by technological advancements like AI-driven diagnostics, point-of-care testing, and smartphone-enabled devices. The focus on personalized medicine and government initiatives to improve healthcare infrastructure also contribute to market growth. Telemedicine and home-based diagnostic solutions, driven by smartphone penetration and wearable health technologies, further fuel global adoption.

For instance, in August 2023, GE HealthCare received FDA clearance for its Portrait Mobile wireless and wearable monitoring solution, which offers real-time continuous monitoring and personalized patient vitals tracking. The platform keeps patients mobile during critical recovery periods, particularly after surgery or intensive care unit discharge.

Geographical Analysis

North America is expected to hold a significant position in the smartphone enabled medical devices market with the highest market share

North America dominates the diagnostic devices market due to its advanced healthcare infrastructure, innovative medical technologies, and key industry players. The rising prevalence of chronic diseases like diabetes, cardiovascular disorders, and cancer drives demand for accurate diagnostics. Government investments, favorable reimbursement policies, telemedicine expansion, home-based diagnostic solutions, and AI-powered devices are accelerating adoption across the region.

For instance, in March 2025, Smart Meter, a leader in remote patient monitoring (RPM) solutions, partnered with FibriCheck to launch their Atrial Fibrillation (Afib) detection app in the U.S. The app uses smartphones as diagnostic tools, enabling users to control their heart health. FibriCheck uses advanced algorithms and the built-in camera on smartphones to detect irregular heart rhythms, potentially signaling Afib, a leading cause of stroke and cardiovascular complications. Smart Meter's seamless integration allows healthcare professionals to access near real-time heart rhythm data, enabling faster intervention and improved patient outcomes.

Competitive Landscape

The major global players in the smartphone enabled medical devices market include Apple Inc, Samsung Electronics, DexCom, Inc, Masimo Corporation, Sonova Holding AG, Oura Health Ltd, Beurer GmbH, Medtronic, Abbott Laboratories, and AliveCor, Inc, among others.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global smartphone enabled medical devices market report delivers a detailed analysis with 62 key tables, more than 55 visually impactful figures and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

3. Market Highlights and Strategic Takeaways

  • 3.1. Key Trends and Future Projections

4. Snippet by Product Type

  • 4.1. Snippet by Application
  • 4.2. Snippet by End-User
  • 4.3. Snippet by Region

5. Dynamics

  • 5.1. Impacting Factors
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Adoption of Telemedicine and Remote Patient Monitoring
      • 5.1.1.2. Increasing Penetration of Smartphones and Mobile Health Apps
    • 5.1.2. Restraints
      • 5.1.2.1. Data Privacy and Security Concerns
      • 5.1.2.2. Regulatory Challenges and Approval Complexities
    • 5.1.3. Opportunity
      • 5.1.3.1. Development of Advanced Biosensors for Real-time Health Tracking
    • 5.1.4. Impact Analysis

6. Strategic Insights and Industry Outlook

  • 6.1. Market Leaders and Pioneers
    • 6.1.1. Emerging Pioneers and Prominent Players
    • 6.1.2. Established leaders with largest selling Brand
    • 6.1.3. Market leaders with established Product
  • 6.2. CXO Perspectives
  • 6.3. Latest Developments and Breakthroughs
  • 6.4. Case Studies/Ongoing Research
  • 6.5. Regulatory and Reimbursement Landscape
    • 6.5.1. North America
    • 6.5.2. Europe
    • 6.5.3. Asia Pacific
    • 6.5.4. Latin America
    • 6.5.5. Middle East & Africa
  • 6.6. Porter's Five Force Analysis
  • 6.7. Supply Chain Analysis
  • 6.8. Patent Analysis
  • 6.9. SWOT Analysis
  • 6.10. Unmet Needs and Gaps
  • 6.11. Recommended Strategies for Market Entry and Expansion
  • 6.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 6.13. Pricing Analysis and Price Dynamics
  • 6.14. Key Opinion Leaders

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Diagnostic Devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Monitoring Devices
  • 7.4. Therapeutic Devices
  • 7.5. Fitness and Wellness Devices
  • 7.6. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Patient Monitoring*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Chronic Disease Management
  • 8.4. Fitness Tracking
  • 8.5. Remote Diagnostics

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals & Clinics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Home Care Settings
  • 9.4. Fitness Centers

10. Regional Market Analysis and Growth Opportunities

11. Introduction

  • 11.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.1. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.6.1. U.S.
      • 11.2.6.2. Canada
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.6.1. Germany
      • 11.3.6.2. U.K.
      • 11.3.6.3. France
      • 11.3.6.4. Spain
      • 11.3.6.5. Italy
      • 11.3.6.6. Rest of Europe
  • 11.4. Latin America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.6.1. Mexico
      • 11.4.6.2. Brazil
      • 11.4.6.3. Argentina
      • 11.4.6.4. Rest of Latin America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.6.1. China
      • 11.5.6.2. India
      • 11.5.6.3. Japan
      • 11.5.6.4. South Korea
      • 11.5.6.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape and Market Positioning

13. Competitive Overview and Key Market Players

  • 13.1. Market Share Analysis and Positioning Matrix
  • 13.2. Strategic Partnerships, Mergers & Acquisitions
  • 13.3. Key Developments in Product Portfolios and Innovations
  • 13.4. Company Benchmarking

14. Company Profiles

  • 14.1. Apple Inc*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio
      • 14.1.2.1. Product Description
      • 14.1.2.2. Product Key Performance Indicators (KPIs)
      • 14.1.2.3. Historic and Forecasted Product Sales
      • 14.1.2.4. Product Sales Volume

15. Financial Overview

  • 15.1. Company Revenue's
    • 15.1.1. Geographical Revenue Shares
      • 15.1.1.1. Revenue Forecasts
    • 15.1.2. Key Developments
      • 15.1.2.1. Mergers & Acquisitions
      • 15.1.2.2. Key Product Development Activities
      • 15.1.2.3. Regulatory Approvals, etc.
    • 15.1.3. SWOT Analysis
  • 15.2. Samsung Electronics
  • 15.3. DexCom, Inc
  • 15.4. Masimo Corporation
  • 15.5. Sonova Holding AG
  • 15.6. Oura Health Ltd
  • 15.7. Beurer GmbH
  • 15.8. Medtronic
  • 15.9. Abbott Laboratories
  • 15.10. AliveCor, Inc LIST NOT EXHAUSTIVE

16. Assumption and Research Methodology

  • 16.1. Data Collection Methods
  • 16.2. Data Triangulation
  • 16.3. Forecasting Techniques
  • 16.4. Data Verification and Validation

17. Appendix

  • 17.1. About Us and Services
  • 17.2. Contact Us